A recent study presented at the EASD in Vienna reveals that over half of adults in Denmark discontinue semaglutide, a weight-loss drug, within a year. Factors contributing to this include the high cost of the medication, adverse side effects, and age.from LifeStyle - Latest Lifestyle News, Hot Trends, Celebrity Styles & Events https://ift.tt/RtQvJuP
